InvestorsHub Logo
Followers 7
Posts 539
Boards Moderated 0
Alias Born 03/17/2011

Re: IanFromSI post# 3145

Wednesday, 07/13/2022 1:42:00 PM

Wednesday, July 13, 2022 1:42:00 PM

Post# of 3191
And here's one from only 2 days ago...

ACADIA Pharmaceuticals (ACAD) Gets a Buy Rating from SVB Securities
July 11 2022 - 08:39AM

In a report released today, Marc Goodman from SVB Securities maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report), with a price target of $27.00. The company's shares closed last Friday at $15.74.

ACADIA Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $22.64, representing a 45.7% upside.

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News